Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  4Sc AG    VSC   DE000A14KL72

4SC AG (VSC)
Mes dernières consult.
Most popular
  Report  
Delayed Quote. Delayed  - 06/22 05:36:27 pm
4.675 EUR   +0.32%
05/224SC AG : 9 upcoming conferences and roadshows
EQ
04/264SC : provides Q1 2018 update
EQ
04/194SC AG : Phase II study of 4SC's resminostat in biliary tract cancer..
EQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

4SC AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/13/2018 | 06:25pm CEST

DGAP Preliminary announcement financial reports: 4SC AG / Preliminary announcement on the disclosure of financial statements
4SC AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

13.03.2018 / 18:22
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


4SC AG hereby announces that the following financial reports shall be disclosed :

Report: Annual financial report
Date of disclosure / German: March 21, 2018 Date of disclosure / English: March 21, 2018 German: https://www.4sc.de/investoren/investoren-informationen/finanzberichte/ English: https://www.4sc.com/investors/investor-information/financial-reports/



13.03.2018 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: 4SC AG
Fraunhoferstr. 22
82152 Planegg-Martinsried
Germany
Internet: www.4sc.com

 
End of News DGAP News Service

663775  13.03.2018 

fncls.ssp?fn=show_t_gif&application_id=663775&application_name=news&site_id=zonebourse

© EQS 2018
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on 4SC AG
05/224SC AG : 9 upcoming conferences and roadshows
EQ
04/264SC : provides Q1 2018 update
EQ
04/194SC AG : Phase II study of 4SC's resminostat in biliary tract cancer in Japan is..
EQ
04/174SC AT AACR : Broadened clinical options for 4SC-202
EQ
04/114SC AG : Yakult Honsha recruits first Japanese patient in 4SC's pivotal RESMAIN ..
EQ
03/274SC : Yakult Honsha joins 4SC's pivotal RESMAIN study of resminostat in CTCL - 4..
EQ
03/214SC : announces results for financial year 2017
EQ
03/154SC : Patent Issued for Substituted Imidazoquinolines (USPTO 9908880)
AQ
03/154SC AG : Conference call to be hosted on 21 March 2018 to present the financial ..
EQ
03/134SC AG : Preliminary announcement of the publication of financial reports accord..
EQ
More news
News from SeekingAlpha
02/064SC (FSCGF) Presents At BioCapital Europe 2018 - Slideshow 
02/033 THINGS IN BIOTECH YOU SHOULD LEARN : February 2, 2018 
20164SC AG Presents at The German Equity Forum 2016 
Financials (€)
Sales 2018 5,95 M
EBIT 2018 -15,2 M
Net income 2018 -14,8 M
Finance 2018 29,1 M
Yield 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 19,2x
EV / Sales 2019 21,8x
Capitalization 143 M
Chart 4SC AG
Duration : Period :
4Sc AG Technical Analysis Chart | VSC | DE000A14KL72 | 4-Traders
Technical analysis trends 4SC AG
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 3,50 €
Spread / Average Target -25%
EPS Revisions
Managers
NameTitle
Jason Loveridge Chief Executive Officer
Clemens M. Doppler Chairman-Supervisory Board
Susanne Danhauser-Riedl Chief Medical Officer
Manfred Rüdiger Member-Supervisory Board
Helmut Jeggle Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
4SC AG-6.11%167
CELLTRION, INC.--.--%33 349
IQVIA HOLDINGS INC6.98%21 424
LONZA GROUP2.35%20 530
INCYTE CORPORATION-22.94%15 692
SEATTLE GENETICS, INC.22.95%10 577